Trump in 30 seconds: Science and medicine in flux

The latest on what the Trump presidency means for health care, hospitals, drug companies, and medical research. Tuesday, Nov. 15 The big news right now Even if Trump ends up being a friend to pharma, the private sector – and particularly pharmacy benefit managers – are set to put increasing pressure on drug prices. (Bloomberg) Some…


Comments are closed.

Biotechblog